Oorsprong van het eerstegraads netwerk van Alexis Smith
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
22
| Subsidiary | Pharmaceuticals: Major | 22 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Alexis Smith via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Tal Medical, Inc.
 Tal Medical, Inc. Medical SpecialtiesHealth Technology Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA. | Medical Specialties | Founder Chief Tech/Sci/R&D Officer Founder | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| Boston College | College/University | Undergraduate Degree Masters Business Admin | |
| Ferris State University (Michigan) | College/University | Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree | |
| University of Illinois | College/University | Undergraduate Degree | |
| University of South Carolina | College/University | Doctorate Degree | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is a non-profit organization based in Chicago, IL and has subsidiaries in the United States. The non-profit company provides information and resources for Alzheimer's and other dementias. Joanne Pike has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| International Council of Ophthalmology Foundation | Director/Board Member | ||
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH. | Hospital/Nursing Management | Director of Finance/CFO | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Parke-Davis Pharmaceutical Research, Inc. | Director/Board Member | ||
| University of Lucknow | College/University | Doctorate Degree | |
| ALLERGAN PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Make-A-Wish Foundation of Illinois | Director/Board Member | ||
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Entrega, Inc.
 Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Michigan Medical School | College/University | Corporate Officer/Principal | |
| ABIVAX | Pharmaceuticals: Other | Director/Board Member | |
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member | |
| PURETECH HEALTH PLC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
PharmaLex GmbH
 PharmaLex GmbH Packaged SoftwareTechnology Services PharmaLex GmbH engages in the provision of specialized services in the fields of development consulting, regulatory affairs, epidemiology and risk management, compliance, as well as quality management, particularly for the pharmaceutical, biotech, and medical device industries. These include providing technical and development support for product development, in-house management of clinical and analytical programs, establishment of pharmacology and regulatory services to ensure approval of pharmaceutical products in certain markets, development of decision-making tools for clinical trial recruitment, and study monitoring and program management. The company was founded in 1994 and is headquartered in Friedrichsdorf, Germany. | Packaged Software | Chief Operating Officer | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Chicago Biomedical Consortium | Director/Board Member | ||
Perception Neuroscience, Inc.
 Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The private company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member | |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Sofinnova Investments, Inc. (Investment Management)
 Sofinnova Investments, Inc. (Investment Management) Investment ManagersFinance Sofinnova Investments, Inc. (Investment Management) (Sofinnova-IM) is the investment management division of Sofinnova Investments, Inc., a venture capital firm headquartered in Menlo Park, California. Founded in 1974, Sofinnova-IM serves as an investment adviser to pooled investment vehicles and separately managed accounts. | Investment Managers | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Verenigd Koninkrijk | 3 |
| India | 2 |
| Ierland | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 136 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 51 |
| Chief Tech/Sci/R&D Officer | 22 |
| Undergraduate Degree | 19 |
Sterkste connecties
| Insiders | |
|---|---|
| James Healy | 50 |
| Steven Paul | 38 |
| Christopher Coughlin | 23 |
| Jeff Jonas | 21 |
| David Wheadon | 21 |
| Atul Pande | 20 |
| Denice Torres | 19 |
| William Meury | 12 |
| Troy Ignelzi | 11 |
| Stephen Brannan | 10 |
| Andrew Miller | 7 |
| James E. Audia | 7 |
| Laurie Olson | 7 |
| Ronald Marcus | 7 |
| Jonathan Rosin | 6 |
- Beurs
- Insiders
- Alexis Smith
- Bedrijfsconnecties
